Energy Specific Far Infrared Radiation Treatment for AIDS
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators are proposing that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of killer cells to fight and destroy the human immunodeficiency virus.
| Condition | Intervention | Phase |
|---|---|---|
|
HIV Infections |
Radiation: Far infrared |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for HIV/AIDS |
- The primary end point is to determine the therapeutic effects of far infrared radiation (5μm to 15μm wavelength) on HIV/AIDS. [ Time Frame: One year ] [ Designated as safety issue: No ]
| Enrollment: | 3 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | November 2009 |
| Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1
Infrared Radiation, wavelength between 5 and 20 microns
|
Radiation: Far infrared
Far infrared radiation with the wavelength between 5μm and 20μm for 30 to 40 minutes per session.
|
Detailed Description:
Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS or Aids) is a collection of symptoms and infections resulting from the specific damage to the immune system caused by the human immunodeficiency virus (HIV) in humans. The late stage of the condition leaves individuals prone to opportunistic infections and tumors. Although treatments for AIDS and HIV exist to slow the virus' progression, there is no known cure.
The investigators are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of CD4+ T cells and other killer cells to fight and destroy the human immunodeficiency virus.
The primary end point is to determine the therapeutic effects of far infrared radiation (5μm to 20μm wavelength) on HIV/AIDS.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 1 Year and above
Exclusion Criteria:
- None
Contacts and Locations| Canada, Ontario | |
| The Centre for Incurable Diseases | |
| Toronto, Ontario, Canada, M4V 1L5 | |
| Principal Investigator: | Ken Nedd, M.D. | GAAD Medical Research Institute Inc. |
| Study Director: | Kwasi Donyina, Ph.D. | GAAD Medical Research Institute Inc. |
More Information
No publications provided
| Responsible Party: | Kwasi Donyina, Ph.D./Founder & President, Centre for Incurable Diseases, GAAD Medical Research Institute Inc. |
| ClinicalTrials.gov Identifier: | NCT00574522 History of Changes |
| Other Study ID Numbers: | GAAD-HIV-CTP1 |
| Study First Received: | December 12, 2007 |
| Last Updated: | August 14, 2009 |
| Health Authority: | Canada: Health Canada |
Keywords provided by GAAD Medical Research Institute Inc.:
|
HIV AIDS Radiation Far infrared |
Treatment Acquired Immunodeficiency Syndrome Complimentary therapies |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on May 22, 2013